1. Introduction {#sec0005}
===============

The innate immune system acts as the first defensive barrier against invading pathogens, using pattern recognition receptors to recognize viral pathogen-associated molecular patterns (PAMPs). Pattern recognition receptors consist of toll-like receptor, nucleotide-binding oligomerization domain protein-like receptors and retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs) ([@bib0075], [@bib0120]). The RLR family is composed of RIG-I, melanoma differentiation-associated gene 5 (MDA5) and laboratory of genetics and physiology 2, all of which play important roles in recognizing viral RNA in the cytoplasm ([@bib0175]). RIG-I and MDA5 both harbor a central DExD/H-box RNA helicase domain, two N-terminal caspase activation and recruitment domains (CARDs), and a C-terminal regulatory domain. The RNA helicase domain is responsible for ATP hydrolysis ([@bib0185], [@bib0180]). The C-terminal regulatory domain is essential for binding viral RNA ([@bib0035], [@bib0170]). The two CARDs function via CARD--CARD interactions with interferon promoter-stimulating factor 1, leading to the activation of interferon regulatory factor 3 and nuclear factor kappa-light chain-enhancer of activated B cells ([@bib0015]), which finally induces type I interferon (IFN-I) production and triggers a series of initial antiviral activities ([@bib0160]). During viral infection, swift upregulation of IFN-I is critical to the host antiviral responses ([@bib0020]). Specifically, the expression of RIG-I and MDA5 are greatly induced by IFN-I as a positive-feedback mechanism, which results in signaling cascade to promote antiviral response ([@bib0040]).

In mammals, RIG-I and MDA5 recognize distinct, but overlapping, families of RNA viruses ([@bib0095], [@bib0140]). However, chickens lack RIG-I and this may provide a rationale for increased susceptibility to certain pathogens in comparison to ducks and mammals, such as Highly Pathogenic Avian Influenza ([@bib0010], [@bib0090]). This suggests that chicken MDA5 (chMDA5) may have an important role in chicken during viral invasion. Unlike ducks and mammals, chMDA5 is able to recognize both long and short poly (I:C) and induce IFN-I beta (IFN-β) expression ([@bib0050], [@bib0090]) and the expression of chMDA5 is upregulated and plays a role during infection with influenza. Interestingly, the expression of chMDA5 does not seem to be sufficient to prevent influenza proliferation ([@bib0090]). A plethora of research exists pertaining to MDA5 function in mammals, little is known about the role of chMDA5 and the ligands that interact with chMDA5. Similar to mammalian MDA5, the expression of chMDA5 is enhanced by IFN-β ([@bib0085], [@bib0105]), but the molecular mechanism is not yet known. A greater understanding of the transcriptional regulation of chMDA5 is essential to elucidating the role of MDA5 in chicken antiviral response.

In the present study, we cloned and characterized a 2.5 kb promoter of chMDA5. This promoter was inserted into a reporter plasmid and transfected into chicken cells to generate a cell model which could be used to investigate the promoter activity. The activity of the promoter reflected the expression of endogenous MDA5, indicating that the system could be used to determine potential MDA5 ligands.

2. Materials and methods {#sec0010}
========================

2.1. Amplification of the 5′- upstream region of chMDA5 gene {#sec0015}
------------------------------------------------------------

An about 2500 bp of the 5′-flanking region of MDA5 gene was amplified using White Leghorn chicken genomic DNA as the template. Primers (F1 and R1, listed in [Table 1](#tbl0005){ref-type="table"} ) were designed according to the sequence published on NCBI GenBank. PCR amplification was performed using KOD-Plus-Neo polymerase (TOYOBO) according to the manufacturer's instruction. The PCR product was cloned into the pMD19-T vector (Takara) to generate the 19T-MDA5 plasmid and was completely sequenced.Table 1Sequences of primers used.Table 1NameSequence (5′to 3′)ApplicationF1TTCTGGAACGCTCTTCTCACApromoter amplificationR1GCACCTTGTCCTTCTCCTCTPciI/BamHIFGCTCACATGTTTCTGGAACGCTCTTCTCACAplasmid constructionPciI/BamHI RGGTGGATCCCGCTGCGCTGGCGGCGCCCGGGCCGGCTCTGCTGCTSfiI/NheI FGGGGAAAAGGCCTCCAAGGCCTTCTGGAACGCTCTTCTCACAplasmid constructionSfiI/NheI RATTCGCTAGCCTTAAGATACATTGATGAGTTTGGDsRed FAGTTCCAGTACGGCTCCAAGGTRT-PCRDsRed RCAGCCCATGGTCTTCTTCTGCATTIFN-α FAACGCCAAAGCCTCCTCAACRT-PCRIFN-α RTTGTCTTGGAGGAAGGTGTGIFN-β FTCCTGCAACCATCTTCGTCART-PCRIFN-β RGCTGCTTGCTTCTTGTCCTTMDA5 FCTGGTTGGGATTGAGACTGTRT-PCRMDA5 RGTCTTTATCCTCTGTTCCTCCTGβ-actin FTACGTCGCACTGGATTTCGART-PCRβ-actin RCAGGACTCCATACCCAAGAA

Seven MDA5 promoter sequences from birds, fish and mammals obtained from the NCBI (<http://www.ncbi.nlm.nih.gov/>), were compared with the chMDA5 promoter sequence. Turkey was chosen to representative for birds that lack RIG-I and duck for birds that have RIG-I. Zebrafish and the mammals all have RIG-I. The tree was generated using MEGA4.0 by the Bootstrap of Test (neighbor-joining method, 1000 replicates; seed = 58150).

2.2. Construction of chMDA5 promoter reporter plasmid {#sec0020}
-----------------------------------------------------

The promoter was amplified using primers designed with a *Pci*I restriction site on the forward primer and a BamHI restriction site on the reverse primer ([Table 1](#tbl0005){ref-type="table"}). The PCR reaction was carried out as described above. The amplification product was purified and double digested with restriction enzymes *Pci*I and BamHI. The purified MDA5 promoter was ligated into the pDsRed1-N1 Vector (CLONTECH) that was previously digested with the same restriction enzymes to replace the CMV promoter. This recombinant plasmid is referred to as the MDA5-DsRed plasmid. Primers were designed with a *Sfi*I restriction site on the forward primer and a NheI restriction site on the reverse primer ([Table 1](#tbl0005){ref-type="table"}) and PCR reaction was carried out using the MDA5-DsRed plasmid as a template to amplify the region containing the MDA5 promoter and the coding region of DsRed. The amplification product was purified and digested with restriction enzymes *Sfi*I and NheI and the purified MDA5-DsRed fragment was ligated into piggybacGFP Plasmid (SBI), which was previously digested with the same restriction enzymes to replace the CMV 7 promoter, generating the piggybac-MDA5-DsRed plasmid.

2.3. Cell culture, transfection and puromycin-selection {#sec0025}
-------------------------------------------------------

DF1, a chicken embryonic fibroblast cell line ([@bib0055]), was cultured in Dulbecco's modified Eagle's medium (DMEM)(GIBCO) supplemented with 3.7 mg/mL sodium bicarbonate, 1 × MEM Non-Essential Amino Acids (GIBCO), 100 U/mL penicillin, 100 ng/mL streptomycin and 10% fetal bovine serum (FBS) (Hyclone), in a 5% CO~2~ incubator at 37 °C. The piggybac-MDA5-DsRed plasmids were transfected into DF1 cells using Lipofectamine^®^ LTX & PLUS™ Reagent (Invitrogen) according to the manufacturer's instructions. 48 h after transfection, 5 μg/mL puromycin was added to the culture media for selection. The continuous cell line was passaged 3--5 times with puromycin selection to obtain a stable cell line containing piggybac-MDA5-DsRed plasmids and that expressed GFP (Piggybac-MDA5-DsRed).

2.4. Poly (I:C), IFN-β and virus challenge {#sec0030}
------------------------------------------

Piggybac-MDA5-DsRed cells were seeded overnight in 12-well plates to 70--80% confluence prior to treatment. For Poly (I:C) challenge, 2.5 μg/mL of long synthetic dsRNA analog poly (I:C) (size:1.5--8 kb) (Invivogen) or 2.5 μg/mL short synthetic dsRNA analog poly(I:C) (size: \<1 kb) (Yuanye) was transfected into cells using Lipofectamine^®^ LTX & PLUS™ Reagent (Invitrogen) according to the manufacturer's instructions. Cells were harvested 24 h post-transfection for fluorescence assay, fluorescence-activated cell sorting (FACS) and qPCR analysis. For IFN-β treatment, 8 μg/mL chicken IFN-β was added into the culture medium for 48 h before the cells were collected for fluorescence assay, FACS and qPCR analysis. For viral challenge, live vaccines of Infectious Bursal Disease Virus (IBDV) NF8, Newcastle Disease Virus (NDV) Lasota and Infectious Bronchitis Virus (IBV) H52, obtained from Qianyuanhao, were diluted with DMEM without FBS and used to replace the culture medium. For the mock treatment, DMEM without FBS was used to replace the culture medium. After 2 h incubation, the diluted virus was replaced with DMEM supplemented with 2% FBS. Cells were observed and collected for analysis 84 h post infection (hpi).

2.5. Gene expression analysis by real-time quantitative PCR {#sec0035}
-----------------------------------------------------------

RNA was extracted using Total RNA kit II (OMEGA) followed by reverse transcription using PrimeScript™ RT Reagent Kit with gDNA Eraser (Perfect Real Time; TaKaRa) according to the manufacturer's instructions. The relative quantitation of gene expression from the Piggybac-MDA5-DsRed cell line following treatment was performed on a LightCycler^®^ 96 (Roche) to determine transcript levels of DsRed, MDA5, IFN-α, IFN-β and β-actin, using the comparative threshold cycle (ΔΔCT) method. 2 μL of cDNA was amplified in a 25 μL reaction using SYBR^®^ Premix Ex Taq II (TliRNaseH Plus; TaKaRa). The corresponding primer sets are listed in [Table 1](#tbl0005){ref-type="table"}. The relative expression levels of target genes were expressed in terms of CT value normalized to β-actin as described previously ([@bib0110]). The fold changes for each gene were normalized to the β-actin expression in each sample. The relative expression of target gene normalized to β-actin is showed as 2^−ΔCT^, where ΔCT = CT ~targetgene~- CT~β-actin~. The relative expression in the treatment group versus that in the mock group was calculated using the formula 2^−ΔΔCT^, where ΔΔCT = ΔCT ~targetgene~ in the treatment group--ΔCT ~targetgene~ in the mock group. The geometric mean of the fold change in expression is shown as log~2~ scale. The mean of ΔΔCT was based on three samples (n = 3).

2.6. Fluorescence activated cell sorting (FACS) analysis {#sec0040}
--------------------------------------------------------

Cells collected for FACS analysis were fixed with 4% paraformaldehyde for 15 min and washed three times using Dulbecco phosphate-buffered saline (SIGMA), then the cell suspensions were prepared in Dulbecco phosphate-buffered saline for FACS analysis. All evaluations were performed on a Moflo XDP flow cytometer (Beckman Coulter) and analyzed using Flow Jo-V10 software.

2.7. Statistical analysis {#sec0045}
-------------------------

Values were expressed as means ± standard deviation and statistical significance among different experimental groups were analyzed by one-way ANOVA using SPSS 18.0 software.

3. Result and discussion {#sec0050}
========================

3.1. Sequence analysis of the promoter region of the chMDA5 gene {#sec0055}
----------------------------------------------------------------

A ∼2.5 kb genomic fragment upstream of the chMDA5 gene was cloned. The fragment sequence was aligned against the 5′-upstream region of chMDA5 gene using the NCBI BLAST Assembled Genomes (<http://blast.ncbi.nlm.nih.gov/Blast>), indicating 99% sequence homology with 5′-promoter region. The full length sequence of the MDA5 promoter has been submitted to the GeneBank database (accession number [KT335979](ncbi-n:KT335979){#intr0020}). Sequence analysis using the TFSEARCH ver.8.3 indicated that the MDA5 promoter region contains several putative transcription factor-binding sites, including binding sites for Sp1, GATA-1, TGGCA-binding protein, AP-1, AP-3, ER-alpha, T3R-alpha, C/EBP alpha, NF-1 (-like proteins) and NF-E4.

In order to exploit the evolutionary relationship of promoters between chicken and other species, a phylogenetic analysis was performed. The chMDA5 promoter demonstrated closer evolutionary distance to bird MDA promoters, than to that of mammals. The closest evolutionary distance was to MDA5 promoter of turkey, in which RIG-I are also absent ([Fig. 1](#fig0005){ref-type="fig"} A). This result was similar to the phylogenetic analysis of the MDA5 gene in previous studies ([@bib0065], [@bib0105], [@bib0165]) and is likely a reflection of the taxonomic relationship between these vertebrates. These results will be helpful for study of the innate immune system regarding to MDA5 and application of this promoter in expression of antiviral genes, as promoters with high homology would possibly bonded to similar transcription factors.Fig. 1The chMDA5 promoter is dramatically activated in transfected cells that are incubated with poly (I:C) and IFN--β, accompanied by upregulation of endogenous MDA5. (A) Phylogenetic tree of the chMDA5 promoter and MDA5 promoter sequences from other birds, fish and mammals. The tree was generated using MEGA4.0 by bootstrapped phylogenetic analysis (neighbor-joining method, 1000 replicates; seed = 58150). (B) Map of recombinant plasmid piggy-pMDA5-DsRed. (C) Immunofluorescence analysis for DsRed from cells treated with mock, long poly (I:C), short poly (I:C) or IFN--β. Scale bars, 100 μm. (D) FACS analysis of DsRed and eGFP from cells treated with mock, long poly (I:C), short poly (I:C) or IFN--β. The horizontal axis represents eGFP-expressing cells and the vertical represents DsRed-expressing cells. The ratios of DsRed and eGFP positive cells are indicated. (E, F) qRT-PCR analysis of cells treated with poly (I:C) (E) and IFN--β (F). The mRNA expression levels of DsRed, eGFP and endogenous MDA5, IFN-α, IFN-β were analyzed by qRT-PCR. Data are presented as means of three independent experiments. Significance was analyzed with one-way ANOVA. The error bars represent the mean of Standard Error. Asterisk represents significant difference between treatment group and the mock (\*p \< 0.05).Fig. 1

3.2. Poly (I:C) and IFN-β challenge increases the activity of the chMDA5 promoter and upregulates endogenous MDA5 expression {#sec0060}
----------------------------------------------------------------------------------------------------------------------------

The chMDA5 promoter reporter plasmid (piggybac-MDA5-DsRed) ([Fig. 1](#fig0005){ref-type="fig"}B), in which the DsRed expression level represents the promoter activity of chMDA5, was transfected into DF-1 cells to investigate the promoter activity. Fluorescence microscope observations ([Fig. 1](#fig0005){ref-type="fig"}C) and FACS analysis ([Fig. 1](#fig0005){ref-type="fig"}D) demonstrated that ∼80% of cultured Piggybac-MDA5-DsRed cells expressed GFP, whereas virtually no DsRed expression could be noted. These results indicated that the MDA5 promoter activity (as observed by DsRed expression) was extremely low under basal conditions.

Previous studies indicated that the chMDA5 recognizes both short and long poly (I:C), with greater preference for short poly (I:C) ([@bib0050]). However, in the present study, though both short and long poly (I:C) could evoke the activity of the MDA5 promoter, short poly (I:C) caused a lesser increase in expression. DsRed-expressing cells were present 24 h post-transfection with poly (I:C) in Piggybac-MDA5-DsRed cells ([Fig. 1](#fig0005){ref-type="fig"}C). The proportion of DsRed-expressing cells transfected with long poly (I:C) and short poly (I:C) were 18% and 10%, respectively ([Fig. 1](#fig0005){ref-type="fig"}D). qRT- PCR results showed that long poly (I:C) dramatically upregulated the DsRed mRNA, which was accompanied by an upregulation of endogenous MDA5, IFN-α and IFN-β. Shor poly (I:C) resulted in a similar effect, although the fold-change was lower for MDA5 and IFN-β and short poly (I:C) stimulation failed to induce IFN-α expression ([Fig. 1](#fig0005){ref-type="fig"}E). Previous results in mda-5^−/−^ mice demonstrated that IFN-β response to poly (I:C) was abrogated, while IFN-α response was lower than the wild-type mice, suggesting that IFN-α was partially independent of MDA5 ([@bib0045]). It is possible that the upregulation of MDA5 by short poly (I:C) is not enough to induce IFN-α in chicken, as the results in this study indicate that chMDA5 preferentially senses long poly (I:C).

As MDA5 is an IFN-inducible gene which primarily responds to IFN-β ([@bib0085]), the MDA5 promoter response to IFN-β was evaluated. The activity of the chMDA5 promoter was increased after 48 h post-treatment with IFN-β, as observed when cells began to express DsRed ([Fig. 1](#fig0005){ref-type="fig"}C). The rate of the DsRed-expressing cells was 2% ([Fig. 1](#fig0005){ref-type="fig"}D). qRT- PCR results showed that the mRNA level of DsRed was significantly enhanced by IFN-β (p \< 0.05), as well as endogenous MDA5 (p \< 0.05) and IFN-β (p \< 0.05) levels. However, IFN-α expression did not change significantly ([Fig. 1](#fig0005){ref-type="fig"}F). The promoter activity was stimulated by IFN-β, with a concurrent increase in MDA5 expression, which is similar to previous reports ([@bib0090]). This confirms that the promoter responds to non-viral inducers, as an indicator of the changes in endogenous MDA5 expression.

3.3. IBDV challenge activates the chMDA5 promoter along with upregulation of endogenous MDA5 {#sec0065}
--------------------------------------------------------------------------------------------

Several different viruses (IBDV, NDV and IBV) were used to infect Piggybac-MDA5-DsRed cells, but only IBDV was able to activate the chMDA5 promoter (1% DsRed expression). Cellular expression of DsRed was coupled with apoptosis that was caused by IBDV infection. However, few cells infected with NDV (0.051%) and IBV (0.12%) infection expressed DsRed ([Fig. 2](#fig0010){ref-type="fig"}A,B ). The level of DsRed expression was remarkably increased by the infection with IBDV (p \< 0.05), as were the mRNA levels of endogenous MDA5 (p \< 0.05), IFN-α (p \< 0.05) and IFN-β (p \< 0.05). In contrast, infection with NDV or IBV had no significant effect on the mRNA levels of DsRed, endogenous MDA5 or IFN-I ([Fig. 2](#fig0010){ref-type="fig"}C). Moreover, the change fold (log2) of expression of DsRed, MDA5 and IFN-1 in an IBDV infection group (about 5--15) is higher than that in NDV infection group and IBV infection group (mainly under 3). The results could be partially explained by differences between single stranded and double stranded RNA, as previous study demonstrated that the expression of chicken MDA5 was highly upregulated during influenza infection, which is a single stranded RNA virus ([@bib0090]). IBDV is a double-stranded RNA virus that belongs to the Birnaviridae family and causes considerable economical loses in the chicken industry ([@bib0130]). In this study, the result supports previous reports that chMDA5 recognizes IBDV and the infection of IBDV (in vitro or in vivo) results in the upregulation of MDA5 and MDA5-related innate immune genes, including IFN-α and IFN-β ([@bib0070], [@bib0110], [@bib0155]). NDV, a negative-stranded RNA virus belonging to paramyxoviruses, which can infect most birds, including chickens ([@bib0005]), is recognized by RIG-I in mammals. In this study, NDV failed to activate the MDA5 promoter and enhance the expression of endogenous MDA5 and IFN-I, in accordance with previous studies. It has been demonstrated that paramyxovirus V proteins can inactivate MDA5 by disrupting the MDA5 ATP-hydrolysis site and preventing the formation of the RNA-bound MDA5 filament ([@bib0125]). Moreover, the V proteins act as IFN-I antagonists inhibiting the increase of IFN-I and blocking binding of IFN to its receptors during NDV infection in DF-1 cells ([@bib0080], [@bib0135]). As a result, the antiviral signaling pathway and the positive-feedback mechanism are blocked, which further inhibits the MDA5 promoter activity. Even so, several studies have reported that NDV induced the expression of IFN-I in chicken splenocytes ([@bib0145]) and macrophages ([@bib0150]) and this discrepancy is likely due to the different cell types used. IBV is a positive-stranded RNA virus belonging to the coronavirus family and causes a highly contagious respiratory disease in poultry ([@bib0025]). Global gene expression profiling has demonstrated that MDA5 expression levels were dramatically increased in chicken kidney tissue infected by Nephropathogenic IBV, while IFN-I expression was not significantly increased ([@bib0030]). Furthermore, a previous study found that MDA5 was the primary sensor of IBV and delayed induction of IFN-β in a cell type-independent manner ([@bib0100]). In contrast, the expression levels of MDA5 and IFN-I were not upregulated and the MDA5 promoter was not activated by IBV infection in the present study, which may be explained by the differences in virulence and adaptability of the IBV strain. In coronaviruses, 2′-O-methylation of viral mRNA can disrupt recognition of the virus by MDA5. In addition, several proteins encoded by some coronaviruses are involved in counteracting IFN-I ([@bib0060], [@bib0115], [@bib0190]). Collectively, the response of the MDA5 promoter to virus inducers was consistent with endogenous MDA5.Fig. 2The chMDA5 promoter is dramatically activated in transfected cells that are infected with IBDV, accompanied by upregulation of endogenous MDA5. Piggybac-MDA5-DsRed cells were infected with IBDV, NDV or IBV. (A) Immunofluorescence analysis for DsRed of cells infected with virus. Cells infected with mock, IBDV, NDV and IBV. Scale bars, 200 μm. (B) FACS analysis of DsRed and eGFP-expressing cells. (C) mRNA expression levels of DsRed, eGFP, endogenous MDA5, IFN-α and IFN-β were analyzed by qRT-PCR. Data are presented as means of three independent experiments. Significance was analyzed with one-way ANOVA. The error bars represent the mean of Standard Error. Asterisk represents significant difference between treatment group and the mock (\*p \< 0.05).Fig. 2

4. Conclusion {#sec0070}
=============

In summary, we cloned and characterized the promoter of chMDA5, establishing a system that can be used to determine the effects of viral or non-viral inducer on chMDA5 expression. Importantly, the chMDA5 promoter could be used to express other antiviral genes, as its activity is extremely low under basal conditions and can be modulated by exogenous inducers. To our knowledge, this study is the first to examine the importance of the 2.5 kb promoter of chMDA5. Our results provide a foundation for future research on the direct regulation of MDA5 expression, which could contribute in developing new strategies against viral infection.
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